RxDoctor Payments Data

Paul Kelly, MD

Otolaryngology/Facial Plastic Surgery · Riverhead, NYNPI 1346242831

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Aerin Medical Inc. at 26.1% of the total. Reporting peaked in 2019 at $433 and has fallen 72.9% since, to $117 in 2025. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in NY, where the typical reported total is $2,391.

$826in general payments, 2019–2025

Across 24 payments — averaging $34.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$215
  • Inspire Medical Systems, Inc.$165
  • GSK$72
  • Intersect ENT, Inc.$59
  • Optinose US, Inc.$55
  • Hikma Pharmaceuticals USA$51
  • plus $209 from 9 others

What the payments were for

  • Food & beverage$826100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$826 in reported general payments places this provider in the 25th percentile of 48 otolaryngology/facial plastic surgery providers in New York.

See all otolaryngology/facial plastic surgery providers in New York

Medicare billing

Part B allowed, 2024
$368,904
Medicare patients
1,141
Services billed
2,805

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluocinolone Acetonide Oil155$7,303
Famotidine319$4,567
Ipratropium Bromide169$3,198
Omeprazole216$3,027
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth24$2,816
Fluticasone Propionate162$2,447
Azelastine-FluticasoneAzelastine/Fluticasone18$2,061
Tobramycin-DexamethasoneTobramycin/Dexamethasone27$877
Pantoprazole Sodium40$746
Mupirocin85$600
Azelastine Hcl17$324
Montelukast Sodium34$291
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim36$141
Amitriptyline Hcl21$135
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$135

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Riverhead

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →